Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aurora Fine Chemicals is a specialized supplier of chemical compounds and services dedicated to drug discovery and development. Founded in 1990, the company offers an extensive collection of over 18 million screening compounds, building blocks, and rare chemicals to the global pharmaceutical and biotechnology sectors. Their core business includes custom synthesis, hit-to-lead optimization, and the provision of focused libraries for specific biological targets. With operations in the United States and Europe, Aurora supports research organizations by providing high-purity chemical entities and comprehensive analytical services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aurora Fine Chemicals.